Intuitive Surgical, Inc. $ISRG Shares Acquired by Nan Shan Life Insurance Co. Ltd.

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Nan Shan Life Insurance Co. Ltd. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14,688.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,223 shares of the medical equipment provider's stock after buying an additional 60,809 shares during the period. Nan Shan Life Insurance Co. Ltd.'s holdings in Intuitive Surgical were worth $30,322,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Colonial Trust Advisors boosted its position in shares of Intuitive Surgical by 5,000.0% in the first quarter. Colonial Trust Advisors now owns 102 shares of the medical equipment provider's stock worth $51,000 after buying an additional 100 shares during the period. BSN CAPITAL PARTNERS Ltd purchased a new stake in shares of Intuitive Surgical in the first quarter worth about $43,088,000. Disciplina Capital Management LLC boosted its position in shares of Intuitive Surgical by 107.3% in the first quarter. Disciplina Capital Management LLC now owns 114 shares of the medical equipment provider's stock worth $56,000 after buying an additional 59 shares during the period. Quantbot Technologies LP boosted its position in shares of Intuitive Surgical by 579.8% in the first quarter. Quantbot Technologies LP now owns 27,613 shares of the medical equipment provider's stock worth $13,676,000 after buying an additional 23,551 shares during the period. Finally, RWA Wealth Partners LLC boosted its position in shares of Intuitive Surgical by 3.6% in the first quarter. RWA Wealth Partners LLC now owns 7,918 shares of the medical equipment provider's stock worth $3,922,000 after buying an additional 275 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 1.3%

NASDAQ:ISRG traded up $6.28 during trading hours on Friday, reaching $476.16. 2,023,902 shares of the stock were exchanged, compared to its average volume of 1,973,062. The firm has a 50 day simple moving average of $504.42 and a 200-day simple moving average of $522.06. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market capitalization of $170.69 billion, a P/E ratio of 66.41, a P/E/G ratio of 4.92 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the business posted $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Wells Fargo & Company upped their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. UBS Group increased their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,839 shares of company stock valued at $7,896,972 in the last quarter. Insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.